BACKGROUND. Bacille Calmette-Guerin (BCG) vaccine is protective against Tuberculosis (TB) in children, but its efficacy wanes with age. Consequently, determining if BCG revaccination augments anti-TB immunity in young adults in TB endemic regions is vital.METHODS. Two hundred healthy adults, BCG vaccinated at birth, were tested for their IFN-gamma release assay (IGRA) status. Of these, 28 IGRA(+) and 30 IGRA(-) were BCG revaccinated, and 24 IGRA(+) and 23 IGRA(-) subjects served as unvaccinated controls. T and innate cell responses to mycobacterial antigens were analyzed by 14-color flow cytometry over 34 weeks.RESULTS. IFN-gamma and/or IL-2 Ag85A- and BCG-specific CD4(+) and CD8(+) T cell responses were boosted by revacciantion at 4 and 34...
Tuberculosis (TB) is the leading cause of mortality from a single infectious agent, Mycobacterium tu...
Recombinant immunodominant mycobacterial antigens are needed for the development of new vaccines and...
MVA85A is a candidate boost vaccine for TB. A previously reported study showed no differences in res...
BACKGROUND. Bacille Calmette-Guerin (BCG) vaccine is protective against Tuberculosis (TB) in childre...
Summary: This study characterized mechanisms of Bacille Calmette-Guérin (BCG) revaccination-induced ...
Mycobacterium bovis bacillus Calmette-Guérin (M. bovis BCG), the only currently available vaccine ag...
<div><p>BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the...
Tuberculosis, caused by infection with Mycobacterium tuberculosis (M.tb), remains a global health pr...
The tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) was introduced 100 years ago, but as it...
BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protect...
Tuberculosis (TB) remains a threat to global health. While advances in diagnostics and treatment are...
There is a need for new vaccines for tuberculosis (TB) that protect against adult pulmonary disease ...
BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protect...
BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protect...
There is a need for new vaccines for tuberculosis (TB) that protect against adult pulmonary disease ...
Tuberculosis (TB) is the leading cause of mortality from a single infectious agent, Mycobacterium tu...
Recombinant immunodominant mycobacterial antigens are needed for the development of new vaccines and...
MVA85A is a candidate boost vaccine for TB. A previously reported study showed no differences in res...
BACKGROUND. Bacille Calmette-Guerin (BCG) vaccine is protective against Tuberculosis (TB) in childre...
Summary: This study characterized mechanisms of Bacille Calmette-Guérin (BCG) revaccination-induced ...
Mycobacterium bovis bacillus Calmette-Guérin (M. bovis BCG), the only currently available vaccine ag...
<div><p>BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the...
Tuberculosis, caused by infection with Mycobacterium tuberculosis (M.tb), remains a global health pr...
The tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) was introduced 100 years ago, but as it...
BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protect...
Tuberculosis (TB) remains a threat to global health. While advances in diagnostics and treatment are...
There is a need for new vaccines for tuberculosis (TB) that protect against adult pulmonary disease ...
BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protect...
BCG vaccine is one of the most commonly-administered vaccines worldwide. Studies suggest the protect...
There is a need for new vaccines for tuberculosis (TB) that protect against adult pulmonary disease ...
Tuberculosis (TB) is the leading cause of mortality from a single infectious agent, Mycobacterium tu...
Recombinant immunodominant mycobacterial antigens are needed for the development of new vaccines and...
MVA85A is a candidate boost vaccine for TB. A previously reported study showed no differences in res...